Amgen, Inc. - Strategy, SWOT and Corporate Finance Report
Amgen, Inc. %li%Strategy, SWOT and Corporate Finance Report
Summary
Amgen, Inc. %li%Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360? view of the company.
Key Highlights
Amgen, Inc., (Amgen or 'the company') is a developer, manufacturer, and marketer of human therapeutics. The company develops products mainly in the areas of oncology/hematology, cardiovascular, neuroscience, bone health, and inflammation. Its product portfolio includes Prolia (denosumab), XGEVA (denosumab), EVENITY (romosozumab), Aimovig (erenumab), Repatha (evolocumab), BLINCYTO (blinatumomab), Aranesp (darbepoetin alfa), KYPROLIS (carfilzomib), Vectibix (panitumumab), Sensipar/Mimpara (cinacalcet), and AMJEVITA (adalimumab-atto). Amgen sells its products through pharmaceutical wholesale distributors and through direct-to-consumer channels, including print, online media, and television. The company has business presence across the US, Europe, Latin America, the Middle East, and Asia-Pacific. The company is headquartered in Thousand Oaks, California, the US.
Scope
Summary
Amgen, Inc. %li%Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360? view of the company.
Key Highlights
Amgen, Inc., (Amgen or 'the company') is a developer, manufacturer, and marketer of human therapeutics. The company develops products mainly in the areas of oncology/hematology, cardiovascular, neuroscience, bone health, and inflammation. Its product portfolio includes Prolia (denosumab), XGEVA (denosumab), EVENITY (romosozumab), Aimovig (erenumab), Repatha (evolocumab), BLINCYTO (blinatumomab), Aranesp (darbepoetin alfa), KYPROLIS (carfilzomib), Vectibix (panitumumab), Sensipar/Mimpara (cinacalcet), and AMJEVITA (adalimumab-atto). Amgen sells its products through pharmaceutical wholesale distributors and through direct-to-consumer channels, including print, online media, and television. The company has business presence across the US, Europe, Latin America, the Middle East, and Asia-Pacific. The company is headquartered in Thousand Oaks, California, the US.
Scope
- Detailed information on Amgen, Inc. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Amgen, Inc. in the form of a SWOT analysis
- An in-depth view of the business model of Amgen, Inc. including a breakdown and examination of key business segments
- Intelligence on Amgen, Inc.'s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Amgen, Inc., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends
- Gain understanding of Amgen, Inc. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Amgen, Inc. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers' businesses better.
- Stay up to date on Amgen, Inc.'s business structure, strategy and prospects.
Table of Contents
Company Snapshot
Amgen, Inc.: Company Overview
Amgen, Inc.: Overview and Key Facts
Amgen, Inc.: Overview
Amgen, Inc.: Key Facts
Amgen, Inc.: Key Employees
Amgen, Inc.: Key Employee Biographies
Amgen, Inc.: Major Products and Services
Amgen, Inc.: Management Statement
Amgen, Inc.: Locations and Subsidiaries
Amgen, Inc.: Key Competitors
Amgen, Inc.: Company Analysis
Amgen, Inc.: Business Description
Amgen, Inc.: SWOT Analysis
Amgen, Inc.: SWOT Overview
Amgen, Inc.: Strengths
Amgen, Inc.: Weaknesses
Amgen, Inc.: Opportunities
Amgen, Inc.: Threats
Amgen, Inc.: Corporate Financial Deals Activity
Amgen, Inc.: Financial Deals Overview
Amgen, Inc.: Targets and Partners
Amgen, Inc.: Top Deals 2019 - 2023YTD*
Amgen, Inc.: Advisors
Amgen, Inc.: Top Legal Advisors
Amgen, Inc.: Top Financial Advisors
Amgen, Inc.: Mergers and Acquisitions
Amgen, Inc.: Corporate Venturing
Amgen, Inc.: Capital Raising
Amgen, Inc.: Partnership
Amgen, Inc.: Divestments
Amgen, Inc.: Recent Developments
Amgen, Inc.: News and Events Summary
Amgen, Inc.: Business Expansion
Amgen, Inc.: Contracts
Amgen, Inc.: Corporate Social Responsibility
Amgen, Inc.: Financial Deals
Amgen, Inc.: Financial Performance
Amgen, Inc.: Market Developments
Amgen, Inc.: Regulatory and Legal Events
Amgen, Inc.: Research & Development
Amgen, Inc.: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine
Company Snapshot
Amgen, Inc.: Company Overview
Amgen, Inc.: Overview and Key Facts
Amgen, Inc.: Overview
Amgen, Inc.: Key Facts
Amgen, Inc.: Key Employees
Amgen, Inc.: Key Employee Biographies
Amgen, Inc.: Major Products and Services
Amgen, Inc.: Management Statement
Amgen, Inc.: Locations and Subsidiaries
Amgen, Inc.: Key Competitors
Amgen, Inc.: Company Analysis
Amgen, Inc.: Business Description
Amgen, Inc.: SWOT Analysis
Amgen, Inc.: SWOT Overview
Amgen, Inc.: Strengths
Amgen, Inc.: Weaknesses
Amgen, Inc.: Opportunities
Amgen, Inc.: Threats
Amgen, Inc.: Corporate Financial Deals Activity
Amgen, Inc.: Financial Deals Overview
Amgen, Inc.: Targets and Partners
Amgen, Inc.: Top Deals 2019 - 2023YTD*
Amgen, Inc.: Advisors
Amgen, Inc.: Top Legal Advisors
Amgen, Inc.: Top Financial Advisors
Amgen, Inc.: Mergers and Acquisitions
Amgen, Inc.: Corporate Venturing
Amgen, Inc.: Capital Raising
Amgen, Inc.: Partnership
Amgen, Inc.: Divestments
Amgen, Inc.: Recent Developments
Amgen, Inc.: News and Events Summary
Amgen, Inc.: Business Expansion
Amgen, Inc.: Contracts
Amgen, Inc.: Corporate Social Responsibility
Amgen, Inc.: Financial Deals
Amgen, Inc.: Financial Performance
Amgen, Inc.: Market Developments
Amgen, Inc.: Regulatory and Legal Events
Amgen, Inc.: Research & Development
Amgen, Inc.: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine
LIST OF TABLES
Table 1: Amgen, Inc.: Key Facts
Table 2: Amgen, Inc.: Key Employees
Table 3: Amgen, Inc.: Locations and Subsidiaries
Table 4: Amgen, Inc.: Key Competitors
Table 5: Amgen, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Table 6: Amgen, Inc.: M&A Activity by Geography (TTM*)
Table 7: Amgen, Inc.: Deal Activity by Deal Type - Volume (2019 - YTD*2023)
Table 8: Amgen, Inc.: M&A Average Deal Size - Value (US$m)
Table 9: Amgen, Inc.: Targets and Partners
Table 10: Amgen, Inc.: Top Deals 2019 - 2023YTD*
Table 11: Amgen, Inc.: Legal Advisor Ranking by Value (US$m)
Table 12: Amgen, Inc.: Financial Advisor Ranking by Value (US$m)
Table 13: Amgen, Inc.: M&A Volume and Value Trend (2019 - YTD*2023)
Table 14: Amgen, Inc.: M&A Activity by Geography (2019 - YTD*2023)
Table 15: Amgen, Inc.: Corporate Venturing Volume and Value Trend (2019 - YTD*2023)
Table 16: Amgen, Inc.: Corporate Venturing by Geography (2019 - YTD*2023)
Table 17: Amgen, Inc.: Capital Raising Volume and Value Trend (2019 - YTD*2023)
Table 18: Amgen, Inc.: Capital Raising by Deal Type (2019 - YTD*2023)
Table 19: Amgen, Inc.: Partnership Volume and Value Trend (2019 - YTD*2023)
Table 20: Amgen, Inc.: Partnership Trend by Deal Type (2019 - YTD*2023)
Table 21: Amgen, Inc.: Divestments Volume and Value Trend (2019 - YTD*2023)
Table 22: Amgen, Inc.: Divestments by Geography (2019 - YTD*2023)
Table 23: Amgen, Inc.: News and Events Summary
Table 24: Amgen, Inc.: Business Expansion
Table 25: Amgen, Inc.: Contracts
Table 26: Amgen, Inc.: Corporate Social Responsibility
Table 27: Amgen, Inc.: Financial Deals
Table 28: Amgen, Inc.: Financial Performance
Table 29: Amgen, Inc.: Market Developments
Table 30: Amgen, Inc.: Regulatory and Legal Events
Table 31: Amgen, Inc.: Research & Development
Table 32: Amgen, Inc.: Strategy and Operations
Table 1: Amgen, Inc.: Key Facts
Table 2: Amgen, Inc.: Key Employees
Table 3: Amgen, Inc.: Locations and Subsidiaries
Table 4: Amgen, Inc.: Key Competitors
Table 5: Amgen, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Table 6: Amgen, Inc.: M&A Activity by Geography (TTM*)
Table 7: Amgen, Inc.: Deal Activity by Deal Type - Volume (2019 - YTD*2023)
Table 8: Amgen, Inc.: M&A Average Deal Size - Value (US$m)
Table 9: Amgen, Inc.: Targets and Partners
Table 10: Amgen, Inc.: Top Deals 2019 - 2023YTD*
Table 11: Amgen, Inc.: Legal Advisor Ranking by Value (US$m)
Table 12: Amgen, Inc.: Financial Advisor Ranking by Value (US$m)
Table 13: Amgen, Inc.: M&A Volume and Value Trend (2019 - YTD*2023)
Table 14: Amgen, Inc.: M&A Activity by Geography (2019 - YTD*2023)
Table 15: Amgen, Inc.: Corporate Venturing Volume and Value Trend (2019 - YTD*2023)
Table 16: Amgen, Inc.: Corporate Venturing by Geography (2019 - YTD*2023)
Table 17: Amgen, Inc.: Capital Raising Volume and Value Trend (2019 - YTD*2023)
Table 18: Amgen, Inc.: Capital Raising by Deal Type (2019 - YTD*2023)
Table 19: Amgen, Inc.: Partnership Volume and Value Trend (2019 - YTD*2023)
Table 20: Amgen, Inc.: Partnership Trend by Deal Type (2019 - YTD*2023)
Table 21: Amgen, Inc.: Divestments Volume and Value Trend (2019 - YTD*2023)
Table 22: Amgen, Inc.: Divestments by Geography (2019 - YTD*2023)
Table 23: Amgen, Inc.: News and Events Summary
Table 24: Amgen, Inc.: Business Expansion
Table 25: Amgen, Inc.: Contracts
Table 26: Amgen, Inc.: Corporate Social Responsibility
Table 27: Amgen, Inc.: Financial Deals
Table 28: Amgen, Inc.: Financial Performance
Table 29: Amgen, Inc.: Market Developments
Table 30: Amgen, Inc.: Regulatory and Legal Events
Table 31: Amgen, Inc.: Research & Development
Table 32: Amgen, Inc.: Strategy and Operations
LIST OF FIGURES
Figure 1: Amgen, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Amgen, Inc.: M&A Activity by Geography (TTM*)
Figure 3: Amgen, Inc.: Deal Activity by Deal Type - Volume (2019 - YTD*2023)
Figure 4: Amgen, Inc.: M&A Average Deal Size - Value (US$m)
Figure 5: Amgen, Inc.: M&A Volume and Value Trend (2019 - YTD*2023)
Figure 6: Amgen, Inc.: M&A Activity by Geography (2019 - YTD*2023)
Figure 7: Amgen, Inc.: Corporate Venturing Volume and Value Trend (2019 - YTD*2023)
Figure 8: Amgen, Inc.: Corporate Venturing by Geography (2019 - YTD*2023)
Figure 9: Amgen, Inc.: Capital Raising Volume and Value Trend (2019 - YTD*2023)
Figure 10: Amgen, Inc.: Capital Raising by Deal Type (2019 - YTD*2023)
Figure 11: Amgen, Inc.: Partnership Volume and Value Trend (2019 - YTD*2023)
Figure 12: Amgen, Inc.: Partnership Trend by Deal Type (2019 - YTD*2023)
Figure 13: Amgen, Inc.: Divestments Volume and Value Trend (2019 - YTD*2023)
Figure 14: Amgen, Inc.: Divestments by Geography (2019 - YTD*2023)
Figure 1: Amgen, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Amgen, Inc.: M&A Activity by Geography (TTM*)
Figure 3: Amgen, Inc.: Deal Activity by Deal Type - Volume (2019 - YTD*2023)
Figure 4: Amgen, Inc.: M&A Average Deal Size - Value (US$m)
Figure 5: Amgen, Inc.: M&A Volume and Value Trend (2019 - YTD*2023)
Figure 6: Amgen, Inc.: M&A Activity by Geography (2019 - YTD*2023)
Figure 7: Amgen, Inc.: Corporate Venturing Volume and Value Trend (2019 - YTD*2023)
Figure 8: Amgen, Inc.: Corporate Venturing by Geography (2019 - YTD*2023)
Figure 9: Amgen, Inc.: Capital Raising Volume and Value Trend (2019 - YTD*2023)
Figure 10: Amgen, Inc.: Capital Raising by Deal Type (2019 - YTD*2023)
Figure 11: Amgen, Inc.: Partnership Volume and Value Trend (2019 - YTD*2023)
Figure 12: Amgen, Inc.: Partnership Trend by Deal Type (2019 - YTD*2023)
Figure 13: Amgen, Inc.: Divestments Volume and Value Trend (2019 - YTD*2023)
Figure 14: Amgen, Inc.: Divestments by Geography (2019 - YTD*2023)
